Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

Medtronic, a global leader in healthcare technology, unveiled results from the Prospective Registry for Assessment of Acute ...

Medtronic holds a dominant share in the market for pulse oximeters, Aboelata said. “Ultimately, we want the FDA to hold themselves and manufacturers accountable for ensuring the devices work for ...

In response to this rising demand, the global market for glucose monitoring devices is projected to experience significant growth, with an anticipated compound annual growth rate (CAGR) of 10.6% over ...

A pair of artificial intelligence algorithms from Boston Scientific and Medtronic can be used by the NHS to monitor heart failure patients with implantable devices, but two others from Biotronik ...

The Centers for Medicare & Medicaid Services granted transitional pass-through (TPT) payment status to Medtronic and Recor Medical for renal denervation devices to treat high blood pressure.

Remote monitoring for patients with implanted cardiac electrophysiology devices may finally be coming of age in the U.K. thanks to a review of these systems by the National Institute for Health and ...

(GPx), a fast-growing MedTech startup revolutionizing chronic disease monitoring and management ... and sales in healthcare and medical devices. Its co-founders Sean Matsuoka and Javier Echenique have ...

For example, Medtronic's continuous glucose monitoring [CGM] systems have taken ... due to their underperformance in the CGM market; the devices that were driving growth get recalled.

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...